Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading?
Publication date: Available online 6 November 2020Source: Best Practice & Research Clinical HaematologyAuthor(s): Jan Philipp Bewersdorf, Amer M. Zeidan
Source: Best Practice and Research Clinical Haematology - Category: Hematology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Hematology | Leukemia | Myelodysplastic Syndrome